Sanofi | Ativo Circulante



Current Assets Alterar Data
AbbVie USD 25.58B 2.2B 2024-12
Amgen USD 26.93B 2.1B 2025-03
AstraZeneca USD 26.14B 312M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Canopy Growth CAD 341.08M 50.58M 2024-12
Corcept Therapeutics USD 438.5M 33.1M 2025-03
Drreddys Laboratories INR 253.02B 4.89B 2024-12
Eli Lilly USD 41.26B 8.52B 2025-03
Galapagos EUR 3.47B 132.9M 2025-03
Genmab DKK 4.04B 23.82B 2025-03
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
Glaxosmithkline GBP 17B 301M 2024-12
Indivior 883M 44M 2025-03
J&J USD 71.55B 15.66B 2025-03
Merck USD 35.5B 3.28B 2025-03
Novartis USD 29.7B 1.56B 2024-12
Novartis USD 29.7B 1.56B 2024-12
Pacira USD 759.96M 14.83M 2025-03
Perrigo USD 2.53B 51.1M 2025-03
Pfizer USD 45.86B 4.5B 2025-03
Prestige Brands USD 448.33M 71.16M 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 44.02B 1.43B 2025-03
Sanofi 42.59B 12.51B 2024-12
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
UCB EUR 4.79B 1.47B 2024-12
Zoetis USD 5.88B 109M 2025-03



Sanofi Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.